$ATS

ATS Corp /ATS

1
1
0

No SEC Form 4 filings for $ATS in the last 30 days.

Med

ATS Q1 Earnings Call Highlights

ATS said it will consolidate some European facilities and shift technical capabilities to sites with capacity. Management expects the first phase to deliver about CAD 20 million in annualized savings, about 30% of the total fixed-cost program (CAD 60-70 million). Q1 restructuring costs were CAD 5.7 million and non-cash charges CAD 21.5 million. ATS guided Q2 revenue to CAD 660-700 million.

ATS Reports First Quarter Fiscal 2027 Results and Announces a Fixed Cost Transformation Program

ATS Corporation reported fiscal 2027 first-quarter results for the three months ended June 28, 2026. Revenues were C$693.7 million versus C$736.7 million a year earlier, with a C$0.3 million net loss. Adjusted EBITDA was C$92.9 million. ATS also announced an 18-month Fixed Cost Transformation Program, targeting 15% adjusted earnings from operations margin, with an initial European footprint consolidation and expected C$20 million annual cost reductions.

Insider Report: BMO executive lands a million-dollar payday

The article lists recent insider selling/option exercises in four stocks. Aritzia’s lead independent director John Currie sold 5,000 shares for about $776,000 (May 28). ATS Corp’s Joe Tassone exercised and sold 4,842 shares for over $100,000 (June 2). Avino’s Carlos Rodriguez sold 56,700 shares for over $570,000 (May 29). BMO’s Sharon Haward-Laird exercised and sold 8,320 shares for over $1.1 million (June 1).

ATS sentiment & insider activity

Over the past 7 days, alphai's AI scored 2 news stories mentioning ATS (ATS Corp /ATS). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.

Recent ATS coverage spans earnings, financial news and corporate actions.

What's driving ATS

  • Restructuring and margin roadmap (fixed-cost savings plus higher-margin services) are the core near-term drivers for ATS’s earnings power and cost trajectory.

    yahoo.com · Aug 7, 2026

  • The new fixed-cost program and the reported Q1 deterioration (revenue down, net loss vs profit) create a near-term earnings and margin narrative, with execution risk on Europe footprint consolidation.

    montrealgazette.com · Aug 6, 2026

  • Option exercise followed by sale is typically liquidity/compensation-related; signal strength is low absent additional context.

    theglobeandmail.com · Jun 8, 2026

  • Guidance and portfolio restructuring details point to modest top-line growth with improving margins, but near-term visibility is pressured by weaker Q4 bookings.

    fool.com · May 29, 2026

  • Small reduction with unchanged outperform suggests limited incremental signal.

    tickerreport.com · May 29, 2026

alphai scores every news story that mentions ATS with an AI model for sentiment and relevance, and aggregates insider trades from ATS Corp /ATS's SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ATS

Score
$ATSMed

ATS Q1 Earnings Call Highlights

ATS said it will consolidate some European facilities and shift technical capabilities to sites with capacity. Management expects the first phase to deliver about CAD 20 million in annualized savings, about 30% of the total fixed-cost program (CAD 60-70 million). Q1 restructuring costs were CAD 5.7 million and non-cash charges CAD 21.5 million. ATS guided Q2 revenue to CAD 660-700 million.

ATS Reports First Quarter Fiscal 2027 Results and Announces a Fixed Cost Transformation Program

ATS Corporation reported fiscal 2027 first-quarter results for the three months ended June 28, 2026. Revenues were C$693.7 million versus C$736.7 million a year earlier, with a C$0.3 million net loss. Adjusted EBITDA was C$92.9 million. ATS also announced an 18-month Fixed Cost Transformation Program, targeting 15% adjusted earnings from operations margin, with an initial European footprint consolidation and expected C$20 million annual cost reductions.

Insider Report: BMO executive lands a million-dollar payday

The article lists recent insider selling/option exercises in four stocks. Aritzia’s lead independent director John Currie sold 5,000 shares for about $776,000 (May 28). ATS Corp’s Joe Tassone exercised and sold 4,842 shares for over $100,000 (June 2). Avino’s Carlos Rodriguez sold 56,700 shares for over $570,000 (May 29). BMO’s Sharon Haward-Laird exercised and sold 8,320 shares for over $1.1 million (June 1).

$ATSMedAI 9/10

ATS (ATS) Q4 2026 Earnings Call Transcript

ATS reported Q4 2026 adjusted revenues of $744 million (+3.2%); organic growth was 1.5% with a 1.7% FX benefit. Q4 adjusted earnings from operations rose 3.4% to $76.8 million; gross margin was 29.4%. Order bookings were $704 million (-18.4%) and backlog about $2 billion. Fiscal 2027 guidance calls for Q1 revenues $700–$740 million and modest full-year growth, with margin improving 50–75 bps.

$ATSMedAI 9/10

ATS Reports Narrower Q4 Loss Due To Higher Revenues, Stock Up

ATS Corporation reported a narrower Q4 2026 net loss for the quarter ended March 31, 2026, citing higher revenues partly offset by higher SG&A. Net loss fell to C$16.2m (from C$68.9m); loss per share to C$0.16 (from C$0.70). Total revenue rose to C$747.1m (from C$574.2m). Outlook for Q1 2027: revenue C$700m–C$740m. Shares closed at $35.27.

$ATSMedAI 9/10

ATS Q4 Earnings Call Highlights

ATS (NYSE:ATS) reported fiscal 2026 revenue and adjusted earnings from operations each up about 11%, with Q4 adjusted revenue at CAD 744 million (+3.2%) and adjusted earnings from operations at CAD 76.8 million (+3.4%). Management outlined restructuring to improve margins and cash, including repositioning transportation, expected to remove ~CAD 50 million of dilutive revenue. Q4 order bookings fell 18.4% to CAD 704 million.

$ATSMed

ATS Corporation (NYSE: ATS) schedules Q4 2026 earnings call and webcast

ATS Corporation (NYSE: ATS) has announced it will report its financial results for the fourth quarter ended March 31, 2026, before markets open on Thursday, May 28, 2026. The company will host a conference call and webcast at 8:30 a.m. Eastern on the same day for management's remarks and an analyst Q&A session. A replay of the call will be available online and via telephone until June 4, 2026.

$ATSMed

ATS Corporation Sets May 28, 2026 Fourth-Quarter Earnings Call

ATS Corporation announced it will release its fourth-quarter fiscal 2026 financial results before markets open on May 28, 2026. The company will also host a conference call and webcast to present management’s remarks and answer analyst questions. TipRanks’ AI Analyst, Spark, rates ATS as Neutral, citing steady growth, solid cash generation, and an improved adjusted profitability, despite very weak reported profitability and an expensive valuation.

Related tickers